img

Global Influenza A Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Influenza A Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Influenza A Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Influenza A Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from 3-18 Years Old and Above 18 Years Old are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Influenza A Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Influenza A Vaccine key manufacturers include Novartis, Sanofi, GSK, Medimmune, Abbott, Mitsubishi Tanabe Pharma, Merck, Sinovac Biotech and Hualan Biological Engineering, etc. Novartis, Sanofi, GSK are top 3 players and held % sales share in total in 2022.
Influenza A Vaccine can be divided into Intramuscular Vaccine and Nasal Spray Vaccine, etc. Intramuscular Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022.
Influenza A Vaccine is widely used in various fields, such as 3-18 Years Old and Above 18 Years Old, etc. 3-18 Years Old provides greatest supports to the Influenza A Vaccine industry development. In 2022, global % sales of Influenza A Vaccine went into 3-18 Years Old filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Influenza A Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novartis
Sanofi
GSK
Medimmune
Abbott
Mitsubishi Tanabe Pharma
Merck
Sinovac Biotech
Hualan Biological Engineering
Changsheng Bio-Technology
Beijing Tiantan Bio-Products
Segment by Type
Intramuscular Vaccine
Nasal Spray Vaccine

Segment by Application


3-18 Years Old
Above 18 Years Old

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Influenza A Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Influenza A Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Influenza A Vaccine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Influenza A Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Influenza A Vaccine introduction, etc. Influenza A Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Influenza A Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Influenza A Vaccine Market Overview
1.1 Influenza A Vaccine Product Overview
1.2 Influenza A Vaccine Market Segment by Type
1.2.1 Intramuscular Vaccine
1.2.2 Nasal Spray Vaccine
1.3 Global Influenza A Vaccine Market Size by Type
1.3.1 Global Influenza A Vaccine Market Size Overview by Type (2024-2034)
1.3.2 Global Influenza A Vaccine Historic Market Size Review by Type (2024-2024)
1.3.3 Global Influenza A Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Influenza A Vaccine Sales Breakdown by Type (2024-2024)
1.4.2 Europe Influenza A Vaccine Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Influenza A Vaccine Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Influenza A Vaccine Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Influenza A Vaccine Sales Breakdown by Type (2024-2024)
2 Global Influenza A Vaccine Market Competition by Company
2.1 Global Top Players by Influenza A Vaccine Sales (2024-2024)
2.2 Global Top Players by Influenza A Vaccine Revenue (2024-2024)
2.3 Global Top Players by Influenza A Vaccine Price (2024-2024)
2.4 Global Top Manufacturers Influenza A Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Influenza A Vaccine Market Competitive Situation and Trends
2.5.1 Influenza A Vaccine Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Influenza A Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza A Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Influenza A Vaccine Market
2.8 Key Manufacturers Influenza A Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Influenza A Vaccine Status and Outlook by Region
3.1 Global Influenza A Vaccine Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Influenza A Vaccine Historic Market Size by Region
3.2.1 Global Influenza A Vaccine Sales in Volume by Region (2024-2024)
3.2.2 Global Influenza A Vaccine Sales in Value by Region (2024-2024)
3.2.3 Global Influenza A Vaccine Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Influenza A Vaccine Forecasted Market Size by Region
3.3.1 Global Influenza A Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Influenza A Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Influenza A Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Influenza A Vaccine by Application
4.1 Influenza A Vaccine Market Segment by Application
4.1.1 3-18 Years Old
4.1.2 Above 18 Years Old
4.2 Global Influenza A Vaccine Market Size by Application
4.2.1 Global Influenza A Vaccine Market Size Overview by Application (2024-2034)
4.2.2 Global Influenza A Vaccine Historic Market Size Review by Application (2024-2024)
4.2.3 Global Influenza A Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Influenza A Vaccine Sales Breakdown by Application (2024-2024)
4.3.2 Europe Influenza A Vaccine Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Influenza A Vaccine Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Influenza A Vaccine Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Influenza A Vaccine Sales Breakdown by Application (2024-2024)
5 North America Influenza A Vaccine by Country
5.1 North America Influenza A Vaccine Historic Market Size by Country
5.1.1 North America Influenza A Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Influenza A Vaccine Sales in Volume by Country (2024-2024)
5.1.3 North America Influenza A Vaccine Sales in Value by Country (2024-2024)
5.2 North America Influenza A Vaccine Forecasted Market Size by Country
5.2.1 North America Influenza A Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Influenza A Vaccine Sales in Value by Country (2024-2034)
6 Europe Influenza A Vaccine by Country
6.1 Europe Influenza A Vaccine Historic Market Size by Country
6.1.1 Europe Influenza A Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Influenza A Vaccine Sales in Volume by Country (2024-2024)
6.1.3 Europe Influenza A Vaccine Sales in Value by Country (2024-2024)
6.2 Europe Influenza A Vaccine Forecasted Market Size by Country
6.2.1 Europe Influenza A Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Influenza A Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Influenza A Vaccine by Region
7.1 Asia-Pacific Influenza A Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Influenza A Vaccine Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Influenza A Vaccine Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Influenza A Vaccine Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Influenza A Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Influenza A Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Influenza A Vaccine Sales in Value by Region (2024-2034)
8 Latin America Influenza A Vaccine by Country
8.1 Latin America Influenza A Vaccine Historic Market Size by Country
8.1.1 Latin America Influenza A Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Influenza A Vaccine Sales in Volume by Country (2024-2024)
8.1.3 Latin America Influenza A Vaccine Sales in Value by Country (2024-2024)
8.2 Latin America Influenza A Vaccine Forecasted Market Size by Country
8.2.1 Latin America Influenza A Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Influenza A Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Influenza A Vaccine by Country
9.1 Middle East and Africa Influenza A Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Influenza A Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Influenza A Vaccine Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Influenza A Vaccine Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Influenza A Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Influenza A Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Influenza A Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis Influenza A Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Novartis Influenza A Vaccine Products Offered
10.1.5 Novartis Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Influenza A Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Sanofi Influenza A Vaccine Products Offered
10.2.5 Sanofi Recent Development
10.3 GSK
10.3.1 GSK Company Information
10.3.2 GSK Introduction and Business Overview
10.3.3 GSK Influenza A Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.3.4 GSK Influenza A Vaccine Products Offered
10.3.5 GSK Recent Development
10.4 Medimmune
10.4.1 Medimmune Company Information
10.4.2 Medimmune Introduction and Business Overview
10.4.3 Medimmune Influenza A Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Medimmune Influenza A Vaccine Products Offered
10.4.5 Medimmune Recent Development
10.5 Abbott
10.5.1 Abbott Company Information
10.5.2 Abbott Introduction and Business Overview
10.5.3 Abbott Influenza A Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Abbott Influenza A Vaccine Products Offered
10.5.5 Abbott Recent Development
10.6 Mitsubishi Tanabe Pharma
10.6.1 Mitsubishi Tanabe Pharma Company Information
10.6.2 Mitsubishi Tanabe Pharma Introduction and Business Overview
10.6.3 Mitsubishi Tanabe Pharma Influenza A Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Mitsubishi Tanabe Pharma Influenza A Vaccine Products Offered
10.6.5 Mitsubishi Tanabe Pharma Recent Development
10.7 Merck
10.7.1 Merck Company Information
10.7.2 Merck Introduction and Business Overview
10.7.3 Merck Influenza A Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Merck Influenza A Vaccine Products Offered
10.7.5 Merck Recent Development
10.8 Sinovac Biotech
10.8.1 Sinovac Biotech Company Information
10.8.2 Sinovac Biotech Introduction and Business Overview
10.8.3 Sinovac Biotech Influenza A Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Sinovac Biotech Influenza A Vaccine Products Offered
10.8.5 Sinovac Biotech Recent Development
10.9 Hualan Biological Engineering
10.9.1 Hualan Biological Engineering Company Information
10.9.2 Hualan Biological Engineering Introduction and Business Overview
10.9.3 Hualan Biological Engineering Influenza A Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Hualan Biological Engineering Influenza A Vaccine Products Offered
10.9.5 Hualan Biological Engineering Recent Development
10.10 Changsheng Bio-Technology
10.10.1 Changsheng Bio-Technology Company Information
10.10.2 Changsheng Bio-Technology Introduction and Business Overview
10.10.3 Changsheng Bio-Technology Influenza A Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Changsheng Bio-Technology Influenza A Vaccine Products Offered
10.10.5 Changsheng Bio-Technology Recent Development
10.11 Beijing Tiantan Bio-Products
10.11.1 Beijing Tiantan Bio-Products Company Information
10.11.2 Beijing Tiantan Bio-Products Introduction and Business Overview
10.11.3 Beijing Tiantan Bio-Products Influenza A Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Beijing Tiantan Bio-Products Influenza A Vaccine Products Offered
10.11.5 Beijing Tiantan Bio-Products Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Influenza A Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Influenza A Vaccine Industrial Chain Analysis
11.4 Influenza A Vaccine Market Dynamics
11.4.1 Influenza A Vaccine Industry Trends
11.4.2 Influenza A Vaccine Market Drivers
11.4.3 Influenza A Vaccine Market Challenges
11.4.4 Influenza A Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Influenza A Vaccine Distributors
12.3 Influenza A Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Intramuscular Vaccine
Table 2. Major Company of Nasal Spray Vaccine
Table 3. Global Influenza A Vaccine Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Influenza A Vaccine Sales by Type (2024-2024) & (K Units)
Table 5. Global Influenza A Vaccine Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Influenza A Vaccine Sales by Type (2024-2024) & (US& Million)
Table 7. Global Influenza A Vaccine Market Share in Value by Type (2024-2024)
Table 8. Global Influenza A Vaccine Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Influenza A Vaccine Sales by Type (2024-2034) & (K Units)
Table 10. Global Influenza A Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Influenza A Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Influenza A Vaccine Sales Market Share in Value by Type (2024-2034)
Table 13. Global Influenza A Vaccine Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Influenza A Vaccine Sales by Type (2024-2024) & (K Units)
Table 15. North America Influenza A Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Influenza A Vaccine Sales (K Units) by Type (2024-2024)
Table 17. Europe Influenza A Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Influenza A Vaccine Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Influenza A Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Influenza A Vaccine Sales (K Units) by Type (2024-2024)
Table 21. Latin America Influenza A Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Influenza A Vaccine Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Influenza A Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Influenza A Vaccine Sales by Company (2024-2024) & (K Units)
Table 25. Global Influenza A Vaccine Sales Share by Company (2024-2024)
Table 26. Global Influenza A Vaccine Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Influenza A Vaccine Revenue Share by Company (2024-2024)
Table 28. Global Market Influenza A Vaccine Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Influenza A Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Influenza A Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza A Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Influenza A Vaccine Market
Table 33. Key Manufacturers Influenza A Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Influenza A Vaccine Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Influenza A Vaccine Sales by Region (2024-2024) & (K Units)
Table 37. Global Influenza A Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Influenza A Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Influenza A Vaccine Sales Market Share in Value by Region (2024-2024)
Table 40. Global Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Influenza A Vaccine Sales by Region (2024-2034) & (K Units)
Table 42. Global Influenza A Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Influenza A Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Influenza A Vaccine Sales Market Share in Value by Region (2024-2034)
Table 45. Global Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Influenza A Vaccine Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Influenza A Vaccine Sales by Application (2024-2024) & (K Units)
Table 48. Global Influenza A Vaccine Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Influenza A Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Influenza A Vaccine Sales Market Share in Value by Application (2024-2024)
Table 51. Global Influenza A Vaccine Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Influenza A Vaccine Sales by Application (2024-2034) & (K Units)
Table 53. Global Influenza A Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Influenza A Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Influenza A Vaccine Sales Market Share in Value by Application (2024-2034)
Table 56. Global Influenza A Vaccine Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Influenza A Vaccine Sales by Application (2024-2024) (K Units)
Table 58. North America Influenza A Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Influenza A Vaccine Sales by Application (2024-2024) (K Units)
Table 60. Europe Influenza A Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Influenza A Vaccine Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Influenza A Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Influenza A Vaccine Sales by Application (2024-2024) (K Units)
Table 64. Latin America Influenza A Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Influenza A Vaccine Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Influenza A Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Influenza A Vaccine Sales by Country (2024-2024) & (K Units)
Table 68. North America Influenza A Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Influenza A Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Influenza A Vaccine Sales Market Share in Value by Country (2024-2024)
Table 71. North America Influenza A Vaccine Sales by Country (2024-2034) & (K Units)
Table 72. North America Influenza A Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Influenza A Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Influenza A Vaccine Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Influenza A Vaccine Sales by Country (2024-2024) & (K Units)
Table 76. Europe Influenza A Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Influenza A Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Influenza A Vaccine Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Influenza A Vaccine Sales by Country (2024-2034) & (K Units)
Table 80. Europe Influenza A Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Influenza A Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Influenza A Vaccine Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Influenza A Vaccine Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Influenza A Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Influenza A Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Influenza A Vaccine Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Influenza A Vaccine Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Influenza A Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Influenza A Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Influenza A Vaccine Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Influenza A Vaccine Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Influenza A Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Influenza A Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Influenza A Vaccine Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Influenza A Vaccine Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Influenza A Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Influenza A Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Influenza A Vaccine Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Influenza A Vaccine Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Influenza A Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Influenza A Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Influenza A Vaccine Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Influenza A Vaccine Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Influenza A Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Influenza A Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Influenza A Vaccine Sales Market Share in Value by Country (2024-2034)
Table 107. Novartis Company Information
Table 108. Novartis Introduction and Business Overview
Table 109. Novartis Influenza A Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Novartis Influenza A Vaccine Product
Table 111. Novartis Recent Development
Table 112. Sanofi Company Information
Table 113. Sanofi Introduction and Business Overview
Table 114. Sanofi Influenza A Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Sanofi Influenza A Vaccine Product
Table 116. Sanofi Recent Development
Table 117. GSK Company Information
Table 118. GSK Introduction and Business Overview
Table 119. GSK Influenza A Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. GSK Influenza A Vaccine Product
Table 121. GSK Recent Development
Table 122. Medimmune Company Information
Table 123. Medimmune Introduction and Business Overview
Table 124. Medimmune Influenza A Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Medimmune Influenza A Vaccine Product
Table 126. Medimmune Recent Development
Table 127. Abbott Company Information
Table 128. Abbott Introduction and Business Overview
Table 129. Abbott Influenza A Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Abbott Influenza A Vaccine Product
Table 131. Abbott Recent Development
Table 132. Mitsubishi Tanabe Pharma Company Information
Table 133. Mitsubishi Tanabe Pharma Introduction and Business Overview
Table 134. Mitsubishi Tanabe Pharma Influenza A Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Mitsubishi Tanabe Pharma Influenza A Vaccine Product
Table 136. Mitsubishi Tanabe Pharma Recent Development
Table 137. Merck Company Information
Table 138. Merck Introduction and Business Overview
Table 139. Merck Influenza A Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Merck Influenza A Vaccine Product
Table 141. Merck Recent Development
Table 142. Sinovac Biotech Company Information
Table 143. Sinovac Biotech Introduction and Business Overview
Table 144. Sinovac Biotech Influenza A Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Sinovac Biotech Influenza A Vaccine Product
Table 146. Sinovac Biotech Recent Development
Table 147. Hualan Biological Engineering Company Information
Table 148. Hualan Biological Engineering Introduction and Business Overview
Table 149. Hualan Biological Engineering Influenza A Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Hualan Biological Engineering Influenza A Vaccine Product
Table 151. Hualan Biological Engineering Recent Development
Table 152. Changsheng Bio-Technology Company Information
Table 153. Changsheng Bio-Technology Introduction and Business Overview
Table 154. Changsheng Bio-Technology Influenza A Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Changsheng Bio-Technology Influenza A Vaccine Product
Table 156. Changsheng Bio-Technology Recent Development
Table 157. Beijing Tiantan Bio-Products Company Information
Table 158. Beijing Tiantan Bio-Products Introduction and Business Overview
Table 159. Beijing Tiantan Bio-Products Influenza A Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. Beijing Tiantan Bio-Products Influenza A Vaccine Product
Table 161. Beijing Tiantan Bio-Products Recent Development
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Influenza A Vaccine Market Trends
Table 165. Influenza A Vaccine Market Drivers
Table 166. Influenza A Vaccine Market Challenges
Table 167. Influenza A Vaccine Market Restraints
Table 168. Influenza A Vaccine Distributors List
Table 169. Influenza A Vaccine Downstream Customers
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza A Vaccine Product Picture
Figure 2. Global Influenza A Vaccine Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Influenza A Vaccine Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Influenza A Vaccine Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Intramuscular Vaccine
Figure 6. Global Intramuscular Vaccine Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Nasal Spray Vaccine
Figure 8. Global Nasal Spray Vaccine Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Influenza A Vaccine Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Influenza A Vaccine Sales Market Share by Type in 2022 & 2034
Figure 11. North America Influenza A Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Influenza A Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Influenza A Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Influenza A Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Influenza A Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Influenza A Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Influenza A Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Influenza A Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Influenza A Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Influenza A Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza A Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza A Vaccine Revenue in 2022
Figure 23. Influenza A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of 3-18 Years Old
Figure 25. Global 3-18 Years Old Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Above 18 Years Old
Figure 27. Global Above 18 Years Old Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Global Influenza A Vaccine Sales by Application (2024-2034) & (US$ Million)
Figure 29. Global Influenza A Vaccine Sales Market Share by Application in 2022 & 2034
Figure 30. North America Influenza A Vaccine Sales Market Share in Volume by Application in 2022
Figure 31. North America Influenza A Vaccine Sales Market Share in Value by Application in 2022
Figure 32. Europe Influenza A Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. Europe Influenza A Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Influenza A Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Influenza A Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Latin America Influenza A Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Influenza A Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Influenza A Vaccine Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Influenza A Vaccine Manufacturing Cost Structure
Figure 41. Influenza A Vaccine Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries